Literature DB >> 29205998

Diabetic nephropathy in type 1 diabetes.

Nektaria Papadopoulou-Marketou1,2, Stavroula A Paschou3, Nikolaos Marketos4, Sofia Adamidi5, Sotiris Adamidis5, Christina Kanaka-Gantenbein3.   

Abstract

Diabetic nephropathy (DN) also named diabetic kidney disease (DN) is one of the leading causes of mortality in people with diabetes. The aim of this review is to update the medical literature, the theories behind its early natural history, the pathways of its pathogenesis, its diagnosis and treatment. Poor glycemic control, hyperlipidemia, smoking, oxidative stress, accumulation of advanced glycated end products, environmental, genetic and epigenetic factors play an important role in the pathophysiological development of DN. Microalbuminuria has been traditionally used as the primary early diagnostic marker of microvascular complication unraveling the risk for progress to severe cardiorenal outcomes, but its prognostic role has been recently debated. The disease often leads to end-stage renal disease and it is often associated with major cardiovascular outcomes. Its early diagnosis is crucial for the patients in order to have a chance for proper treatment.

Entities:  

Mesh:

Year:  2017        PMID: 29205998     DOI: 10.23736/S0026-4806.17.05496-9

Source DB:  PubMed          Journal:  Minerva Med        ISSN: 0026-4806            Impact factor:   4.806


  24 in total

1.  Preventive effect of exercise training on diabetic kidney disease in ovariectomized rats with type 1 diabetes.

Authors:  Cláudia Silva Souza; Bianca Silva de Sousa Oliveira; Geovanildo Nascimento Viana; Thiago Macêdo Lopes Correia; Ana Carolina de Bragança; Daniele Canale; Márcio Vasconcelos Oliveira; Amélia Cristina Mendes de Magalhães; Rildo Aparecido Volpini; Liliany Souza de Brito Amaral; Telma de Jesus Soares
Journal:  Exp Biol Med (Maywood)       Date:  2019-05-01

2.  Concurrent Presentation of Diabetic Nephropathy and Type 1 Diabetes Mellitus in a Pediatric Patient.

Authors:  Sana Manazir; Hafiza M Durrani; Fatima Jawed; Hira Iqbal Naviwala
Journal:  Cureus       Date:  2021-12-30

3.  Berberine Improves the Protective Effects of Metformin on Diabetic Nephropathy in db/db Mice through Trib1-dependent Inhibiting Inflammation.

Authors:  Bin Zhang; Xuelian Zhang; Chenyang Zhang; Guibo Sun; Xiaobo Sun
Journal:  Pharm Res       Date:  2021-11-12       Impact factor: 4.200

4.  The nephroprotective action of Passiflora edulis in streptozotocin-induced diabetes.

Authors:  Ony Araújo Galdino; Iago de Souza Gomes; Renato Ferreira de Almeida Júnior; Maria Imaculada Conceição Ferreira de Carvalho; Bento João Abreu; Marcela Abbott Galvão Ururahy; Barbara Cabral; Silvana Maria Zucolotto Langassner; Karla Simone Costa de Souza; Adriana Augusto de Rezende
Journal:  Sci Rep       Date:  2022-10-20       Impact factor: 4.996

Review 5.  Influence of exercise training on diabetic kidney disease: A brief physiological approach.

Authors:  Liliany Souza de Brito Amaral; Cláudia Silva Souza; Hernando Nascimento Lima; Telma de Jesus Soares
Journal:  Exp Biol Med (Maywood)       Date:  2020-06-02

Review 6.  Human umbilical cord mesenchymal stem cells in type 2 diabetes mellitus: the emerging therapeutic approach.

Authors:  Andreia Gomes; Pedro Coelho; Raquel Soares; Raquel Costa
Journal:  Cell Tissue Res       Date:  2021-05-29       Impact factor: 5.249

7.  The Sodium-Glucose Cotransporter 2 Inhibitor Dapagliflozin Prevents Renal and Liver Disease in Western Diet Induced Obesity Mice.

Authors:  Dong Wang; Yuhuan Luo; Xiaoxin Wang; David J Orlicky; Komuraiah Myakala; Pengyuan Yang; Moshe Levi
Journal:  Int J Mol Sci       Date:  2018-01-03       Impact factor: 5.923

Review 8.  Impact of Astaxanthin on Diabetes Pathogenesis and Chronic Complications.

Authors:  Rebecca Landon; Virginie Gueguen; Hervé Petite; Didier Letourneur; Graciela Pavon-Djavid; Fani Anagnostou
Journal:  Mar Drugs       Date:  2020-07-09       Impact factor: 5.118

9.  Emodin Attenuated the Kidney Damage of High-Fat-Diet Mice via the Upregulation of Glucagon-Like Peptide-1 Receptor.

Authors:  Jinlei Liu; Yao Sun; Hongwei Zheng; Jing Wang; Lili Liu; Bing Song; Haoqiang Zhang
Journal:  Biomed Res Int       Date:  2021-05-31       Impact factor: 3.411

10.  MiR-142-3p ameliorates high glucose-induced renal tubular epithelial cell injury by targeting BOD1.

Authors:  Ningmin Zhao; Qing Luo; Ruijuan Lin; Qiaoyan Li; Peizhi Ma
Journal:  Clin Exp Nephrol       Date:  2021-06-18       Impact factor: 2.617

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.